James E. Dawson is a partner in the Business Department and a member of the firm's Life Sciences group. He practices in the areas of corporate and securities law, including mergers and acquisitions, public offerings, private placements and investment adviser representation. He represents life sciences companies, including biotech and medical device companies, and life science venture funds, as well as emerging and high tech companies.
Jim has handled more than 100 mergers and acquisitions of both public and private buyers and sellers. He represents public companies, handling all facets of securities law issues, including compliance with Sarbanes-Oxley. Jim is a former co-chair of the Boston Bar Association’s Securities Law Committee and has been a frequent lecturer at Massachusetts Continuing Legal Education. He also represents companies based in Europe and Asia doing business in the U.S.
Jim is a member of the American, Massachusetts and Boston Bar Associations.